Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3171/CASE25555 http://scihub22266oqcxt.onion/10.3171/CASE25555 41343798!?!41343798 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=41343798&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Neurosurg+Case+Lessons 2025 ; 10 (21): ? Nephropedia Template TP {{tp|p=41343798|t=2025. Candida glabrata vertebral osteomyelitis following L3-4 transforaminal lumbar fusion: illustrative case |pdf=|usr=}}{{41343798}} gab.com Text Candida glabrata vertebral osteomyelitis following L3-4 transforaminal lumbar fusion: illustrative case JO: J Neurosurg Case Lessons http://www.kidney.de/pget.php?&tw=1&pmid=41343798 #FOAvip BACKGROUND: Candida vertebral osteomyelitis is rare, particularly following instrumented spine surgery. Candida glabrata presents additional management challenges due to its frequent resistance to azole antifungal treatment and its association with immunocompromised hosts. OBSERVATIONS: A 74-year-old immunosuppressed man underwent L3-4 transforaminal lumbar interbody fusion with cyst excision. Seven weeks postoperatively, he presented with constitutional symptoms and elevated inflammatory markers but was discharged with presumed viral illness. Nine months after surgery, imaging revealed cage displacement. Intraoperative cultures during hardware removal identified C. glabrata. The patient underwent repeat irrigation and debridement with hardware exchange and was treated with intravenous micafungin and oral fluconazole and later transitioned to posaconazole. Despite ongoing antifungal therapy, inflammatory markers remained elevated, and follow-up imaging showed progressive vertebral destruction without hardware failure. The patient continues on chronic antifungal suppression with multidisciplinary monitoring. LESSONS: This case highlights the diagnostic and therapeutic challenges of postoperative C. glabrata vertebral osteomyelitis. Early suspicion, culture confirmation, and organism-specific antifungal therapy, alongside timely surgical management, are critical to achieving infection control and preserving spinal stability in immunosuppressed patients. https://thejns.org/doi/10.3171/CASE25555. Twit Text FOAVip Candida glabrata vertebral osteomyelitis following L3-4 transforaminal lumbar fusion: illustrative case ????J Neurosurg Case Lessons http://www.kidney.de/pget.php?&tw=1&pmid=41343798 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=41343798 #FOAvip English Wikipedia <ref>{{Cite pmid|41343798}}</ref> Candida glabrata vertebral osteomyelitis following L3-4 transforaminal lumbar fusion: illustrative case #MMPMID41343798 Michael BR; Youssef A; Grafton P; Mostafa S; Sayegh J; Robles LA; Alhammoud A J Neurosurg Case Lessons 2025[Nov]; 10 (21): ? PMID41343798show ga BACKGROUND: Candida vertebral osteomyelitis is rare, particularly following instrumented spine surgery. Candida glabrata presents additional management challenges due to its frequent resistance to azole antifungal treatment and its association with immunocompromised hosts. OBSERVATIONS: A 74-year-old immunosuppressed man underwent L3-4 transforaminal lumbar interbody fusion with cyst excision. Seven weeks postoperatively, he presented with constitutional symptoms and elevated inflammatory markers but was discharged with presumed viral illness. Nine months after surgery, imaging revealed cage displacement. Intraoperative cultures during hardware removal identified C. glabrata. The patient underwent repeat irrigation and debridement with hardware exchange and was treated with intravenous micafungin and oral fluconazole and later transitioned to posaconazole. Despite ongoing antifungal therapy, inflammatory markers remained elevated, and follow-up imaging showed progressive vertebral destruction without hardware failure. The patient continues on chronic antifungal suppression with multidisciplinary monitoring. LESSONS: This case highlights the diagnostic and therapeutic challenges of postoperative C. glabrata vertebral osteomyelitis. Early suspicion, culture confirmation, and organism-specific antifungal therapy, alongside timely surgical management, are critical to achieving infection control and preserving spinal stability in immunosuppressed patients. https://thejns.org/doi/10.3171/CASE25555. ?Candida glabrata vertebral osteomyelitis following L3-4 transforaminal(epmc).pdf DeepDyve Pubget Overpricing